IP Library › Assignment 015156/0196
Patent Assignment
Reel/Frame 015156/0196

Assignment of Assignor's Interest

Recorded: 2004-09-13 Pages: 26
Assignor
Assignee
H. LUNDBECK A/S
OTTILIAVEJ 9,, COPENHAGEN-VALBY, DK-2000, DENMARK
Covered Properties (146)
Dna Encoding a Human Dopamine D1 Receptor and Uses Thereof
Patent: 6,939,680 →
Application: 10/277,078 →
Publication: US 2003/0049794
DNA encoding human alpha 1 adrenergic receptors and uses thereof
Application: 10/238,129 →
Publication: US 2003/0113771
Nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors and uses thereof
Application: 10/188,619 →
Publication: US 2003/0162944
Method of Obtaining Compositions Comprising Y4 Specific Compounds
Patent: 6,913,892 →
Application: 09/430,775 →
Methods of Modifying Feeding Behavior, Compounds Useful in Such Methods, and Dna Encoding a Hypothalamic Atypical Neuropeptide Y/Peptide Yy Receptor (Y5)
Patent: 6,818,445 →
Application: 09/962,646 →
Publication: US 2002/0103123
Methods of Modifying Feeding Behavior, Compounds Useful in Such Methods, and Dna Encoding a Hypothalamic Atypical Neuropeptide Y/Peptide Yy Receptor (Y5)
Patent: 6,713,265 →
Application: 09/194,895 →
Uses of Galanin GALR2 Receptors
Patent: 7,132,248 →
Application: 10/285,019 →
Publication: US 2003/0215823
Method of Preparing GALR2 Receptors Composition
Patent: 7,060,449 →
Application: 10/298,992 →
Publication: US 2003/0129702
Method of treating an abnormality using a GALR3 receptor antagonist
Application: 10/006,343 →
Publication: US 2003/0119096
Processes for Preparing Compositions Involving GALR3 Receptor Specific Compounds
Patent: 7,022,489 →
Application: 10/007,132 →
Publication: US 2003/0027254
Dna Encoding a Gaba B R2 Polypeptide and Uses Thereof
Application: 09/211,755 →
Publication: US 2002/0045742
Dna Encoding a GABABR2 Polypeptide and Uses Thereof
Application: 09/818,879 →
Publication: US 2001/0023289
DNA encoding a GABABR2 polypeptide and uses thereof
Application: 09/793,139 →
Publication: US 2002/0156265
Dna Encoding SNORF25 Receptor
Patent: 7,416,848 →
Application: 10/278,437 →
Publication: US 2003/0139590
DNA encoding SNORF25 receptor
Application: 10/278,455 →
Publication: US 2003/0125539
Processes for Identifying Compounds That Bind to the Human NPFF2 Receptor
Patent: 6,709,831 →
Application: 09/405,558 →
Dna Encoding Mammalian Neuropeptide Ff (Npff) Receptors and Uses Thereof
Patent: 6,849,727 →
Application: 09/538,036 →
DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
Application: 09/899,732 →
Publication: US 2003/0082623
DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
Application: 10/029,314 →
Publication: US 2003/0077701
Dna Encoding a Human Melanin Concentrating Hormone Receptor (MCH1) and Uses Thereof
Patent: 6,723,552 →
Application: 09/885,478 →
Publication: US 2002/0111306
DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
Application: 10/341,751 →
Publication: US 2004/0038855
DNA encoding Edg7 receptor
Application: 10/228,762 →
Publication: US 2003/0130493
Receptor agonists useful for the treatment of pain
Application: 10/188,425 →
Publication: US 2003/0022839
Dna Encoding SNORF36 Receptors
Patent: 7,029,914 →
Application: 10/146,835 →
Publication: US 2003/0073167
Compositions Comprising SNORF36 Receptor Compounds
Patent: 7,037,665 →
Application: 10/018,192 →
Dna Encoding SNORF33 Receptor
Patent: 6,987,005 →
Application: 09/980,145 →
Inhibition of Cytotoxic Agent-Induced Intestinal Injury Comprising Pretreatment with a Glp-2 Receptor Activator
Application: 10/267,217 →
Publication: US 2003/0105318
Chimeric G Proteins and Uses Thereof
Patent: 7,067,277 →
Application: 09/471,572 →
Processes for Obtaining Compounds Employing SNORF72 Receptors
Patent: 7,029,857 →
Application: 09/609,146 →
DNA encoding orphan SNORF66 receptor
Application: 10/307,736 →
Publication: US 2003/0083488
DNA encoding SNORF138 and uses thereof
Application: 10/679,185 →
Publication: US 2004/0214237
Compositions comprising alpha-1C specific compounds
Application: 10/185,991 →
Publication: US 2003/0022900
5- (Heterocyclic Alkyl) -6-Aryl- Dihydropyrimidines
Patent: 6,727,257 →
Application: 09/730,458 →
System and Method for Managing Storage Space of a Cache
Patent: 6,654,856 →
Application: 09/855,957 →
Publication: US 2002/0174302
Imidazole and Imidazoline Derivatives and Uses Thereof
Patent: 6,777,426 →
Application: 09/933,106 →
Publication: US 2002/0019390
Benzimidazoles and Benzothiazoles and Uses Thereof
Patent: 6,723,741 →
Application: 10/278,608 →
Publication: US 2003/0105147
Use of agonists or antagonists of the 5-HT7 receptor to treat disorders of the bladder
Application: 10/228,779 →
Publication: US 2003/0032580
Aryl Sulfonamides and Sulfamide Derivatives and Uses Thereof
Patent: 6,734,182 →
Application: 10/114,597 →
Publication: US 2003/0013714
Compounds Specific for the Human ALPHA1D Adrenergic Receptor and Uses Thereof
Patent: 6,706,716 →
Application: 09/764,710 →
Publication: US 2002/0028760
Compounds specific for the human alpha1d adrenergic receptor and uses thereof
Application: 10/718,934 →
Publication: US 2004/0106623
Dihydropyrimidines and Uses Thereof
Patent: 6,680,323 →
Application: 09/873,746 →
Publication: US 2001/0041707
Dihydropyrimidines and uses thereof
Application: 10/702,579 →
Publication: US 2004/0138242
Selective NPY (Y5) antagonists (triazines)
Application: 10/420,238 →
Publication: US 2004/0019050
Selective Npy (Y5) Antagonists
Patent: 6,989,379 →
Application: 10/009,849 →
Selective npy (y5) antagonists
Application: 10/019,881 →
Molecules specific for NPFF receptors and uses thereof
Application: 10/253,288 →
Publication: US 2003/0144310
Use of GAL3 Antagonist for Treatment of Depression
Application: 10/723,961 →
Publication: US 2004/0127502
Use of GALR3 Receptor Antagonists for the Treatment of Depression and/or Anxiety and Compounds Useful in Such Methods
Patent: 7,081,470 →
Application: 10/414,660 →
Publication: US 2004/0102507
Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptors
Application: 10/253,946 →
Publication: US 2003/0139431
Selective Melanin Concentrating Hormone-1 (MCH1) Receptor Antagonists and Uses Thereof
Patent: 6,720,324 →
Application: 09/899,635 →
Publication: US 2003/0069261
Substituted Anilinic Piperidines as Mch Selective Antagonists
Patent: 6,727,264 →
Application: 10/188,434 →
Substituted Anilinic Piperidines as Mch Selective Antagonists
Patent: 7,067,534 →
Application: 10/719,358 →
Substituted anilinic piperidines as mch selective antagonists
Application: 10/481,558 →
Substituted Alkyl Amido Piperidines
Patent: 7,105,544 →
Application: 10/345,063 →
Publication: US 2006/0041139
Compounds for the treatment of pain
Application: 10/253,237 →
Publication: US 2003/0176314
3-Imino-2-Indolones for the Treatement of Depression and/or Anxiety
Application: 10/637,971 →
Publication: US 2004/0082615
2,4,6-Triaminopyrimidines for the Treatment of Depression and/or Anxiety
Patent: 6,936,607 →
Application: 10/638,602 →
Publication: US 2004/0082587
Compound Useful for the Treatment of Neuropathic Pain
Patent: 7,220,775 →
Application: 10/637,299 →
Publication: US 2004/0092570
GAL3 receptor antagonists for the treatment of affective disorders
Application: 10/638,242 →
Publication: US 2004/0110821
Processes and polymorphs of diaryl-indolone galr3 antagonists
Application: 10/637,214 →
Publication: US 2005/0192337
Dna Encoding an ALPHA2B-Adrenergic Receptor
Patent: 5,053,337 →
Application: 07/428,856 →
Use of Alpha-1C Specific Compounds to Treat Benign Prostatic Hyperplasia
Patent: 5,403,847 →
Application: 07/975,867 →
Functionalization of Acyl Pyridinium Salts
Patent: 5,453,509 →
Application: 08/134,179 →
Novel Aromatic Amine Derivatives
Patent: 5,508,306 →
Application: 08/124,501 →
Dna Encoding a Human Neuropeptide Y/Peptide Yy/Pancreatic Polypeptide Receptor (Y4) and Uses Thereof
Patent: 5,516,653 →
Application: 08/176,412 →
Dna Encoding a Human Neuropeptide Y/Peptide Yy (Y2) Receptor and Uses Thereof
Patent: 5,545,549 →
Application: 08/192,288 →
Dna Encoding Human Alpha 1 Adrenegric Receptors and Uses Thereof
Patent: 5,556,753 →
Application: 08/334,698 →
Use of Alpha-1C Specific Compounds to Treat Benign Prostatic Hyperplasia
Patent: 5,578,611 →
Application: 08/228,932 →
Dna Encoding an Alpha Adrenergic Receptor and Uses Thereof 2B
Patent: 5,595,880 →
Application: 07/965,040 →
Dna Encoding a Hypothalamic Atypical Neuropeptide Y/Peptide Yy Receptor (Y5) and Uses Thereof
Patent: 5,602,024 →
Application: 08/349,025 →
Use of Alpha-1C-Selective Adrenoceptor Agonists for the Treatment of Urinary Incontinence
Patent: 5,610,174 →
Application: 08/459,410 →
5-And 6-(2-Imidazolin-2-Ylamino) and -2-Thiazolin-2-Ylamino)- Benzothiazoles as Alpha-2 Adrenergic Ligands
Patent: 5,677,321 →
Application: 08/608,598 →
Dna Encoding Human Alpha 1 Adrenergic Receptors and Uses Thereof
Patent: 5,714,381 →
Application: 08/468,939 →
Dna Encoding a Glycine Transporter and Uses Thereof
Patent: 5,756,348 →
Application: 08/240,783 →
Dihydropyridines and New Uses Thereof
Patent: 5,767,131 →
Application: 08/211,764 →
Use of Alpha-1C Specific Compounds to Treat Benign Prostatic Hyperplasia
Patent: 5,780,485 →
Application: 08/415,681 →
Dna Encoding Human Alpha 1 Adrenergic Receptors
Patent: 5,861,309 →
Application: 08/406,855 →
Imidazole and Imidazoline Derivatives and Uses Thereof
Patent: 5,866,579 →
Application: 08/834,658 →
Dna Encoding a Human Dopamine D1 Receptor and Uses Thereof
Patent: 5,882,855 →
Application: 07/969,267 →
Dihydropyrimidines and New Uses Thereof
Patent: 5,942,517 →
Application: 08/978,682 →
Substituted Indoles and Uses Thereof
Patent: 5,948,804 →
Application: 08/926,316 →
Process for Identifying Compounds That Bind to the Human Y4 Receptor
Patent: 5,958,709 →
Application: 08/555,268 →
Dna Encoding a Hypothalamic Atypical Neuropeptide Y/Peptide Yy Receptor (Y5)
Patent: 5,968,819 →
Application: 08/566,096 →
A Method of Identifying Ligands Which Bind Recombinant Galanin Receptor(Galrz)
Patent: 5,972,624 →
Application: 08/626,685 →
Dna Encoding a Human Neuropeptide Y/Peptide Yy/Pancreatic Polypeptide Receptor (Y4) and Uses Thereof
Patent: 5,976,814 →
Application: 08/495,695 →
Uses of Nucleic Acid Encoding Neuropeptide Y/Peptide Yy (Y2) Receptors
Patent: 5,989,834 →
Application: 08/687,355 →
Methods of Modifying Feeding Behavior Compounds Useful in Such Methods and Dna Encoding a Hypothalmic Atypical Neuropeptide Y/Peptide Yy Receptor Y5
Patent: 5,989,920 →
Application: 08/668,650 →
Alpha-1C Specific Compounds to Treat Benign Prostatic Hyperplasia
Patent: 5,990,128 →
Application: 08/722,190 →
Use of Alpha-1C Specific Compounds to Treat Benign Prostatic Hyperplasia
Patent: 6,015,819 →
Application: 08/244,354 →
Substituted Indoles and Uses Thereof
Patent: 6,040,451 →
Application: 09/345,470 →
Imidazolones and Their Use in Treating Benign Prostatic Hyperplasia and Other Disorders
Patent: 6,046,331 →
Application: 09/213,078 →
Dna Encoding Human Alpha 1 Adrenergic Receptors and Uses Thereof
Patent: 6,083,705 →
Application: 09/206,899 →
Imidazole and Imidazoline Derivatives and Uses Thereof
Patent: 6,093,727 →
Application: 09/175,253 →
Dna Encoding SNORF1 Receptor
Patent: 6,117,990 →
Application: 09/286,805 →
Selective Npy (Y5) Antagonists (Tricyclics)
Patent: 6,124,331 →
Application: 09/343,994 →
Dna Encoding a Glycine Transporter and Uses Thereof
Patent: 6,127,131 →
Application: 09/084,813 →
Dna Encoding Human Alpha 1 Adrenergic Receptors and Uses Thereof
Patent: 6,156,518 →
Application: 09/474,551 →
Oxxazolidinones as Alpha 1A Receptor Antagonists
Patent: 6,159,990 →
Application: 09/099,225 →
Substituted indoles and uses thereof
Patent: 6,159,998 →
Application: 09/492,505 →
Dihydropyrimidines and Uses Thereof
Patent: 6,172,066 →
Application: 08/858,061 →
Dihydropyridines and New Uses Thereof
Patent: 6,211,198 →
Application: 09/098,699 →
Aryl Sulfonamides and Sulfamide Derivatives and Uses Thereof
Patent: 6,211,241 →
Application: 09/088,450 →
Selective Npy (Y5) Antagonists (Bicyclics)
Patent: 6,214,853 →
Application: 09/343,633 →
Morpholinone and Morpholine Derivatives and Uses Thereof
Patent: 6,218,390 →
Application: 09/213,539 →
Selective Npy (Y5) Antagonists (Bicyclics)
Patent: 6,218,408 →
Application: 09/343,762 →
Dna Encoding a Human Melanin Concentrating Hormone Receptor (MCH1) and Uses Thereof
Patent: 6,221,613 →
Application: 09/224,426 →
Dna Encoding a Human Melanin Concentrating Hormone Receptor (MCH1) and Uses Thereof
Patent: 6,221,616 →
Application: 09/478,601 →
Dna Encoding SNORF25 Receptor
Patent: 6,221,660 →
Application: 09/387,699 →
Selective Npy (Y5) Antagonists (Tricyclics)
Patent: 6,222,040 →
Application: 09/343,993 →
Selective Npy (Y5) Antagonists (Tricyclics)
Patent: 6,225,330 →
Application: 09/343,635 →
Dihydropyrimidines and Uses Thereof
Patent: 6,228,861 →
Application: 09/068,782 →
Dihydropyrimidines and Uses Thereof
Patent: 6,245,773 →
Application: 08/858,017 →
Dihydropyrimidines and New Uses Thereof
Patent: 6,248,747 →
Application: 09/291,553 →
Dna Encoding Mammalian Neuropeptides Ff (Npff) Receptors and Uses Thereof
Patent: 6,262,246 →
Application: 09/255,368 →
Dihydropyrimidines and Uses Thereof
Patent: 6,268,369 →
Application: 08/836,628 →
Dihydropyrimidines and Uses Thereof
Patent: 6,274,585 →
Application: 09/470,691 →
Dna Encoding Galanin GALR3 Receptors and Uses Thereof
Patent: 6,287,788 →
Application: 09/199,737 →
Dna Encoding a Human Melanin Concentrating Hormone Receptor (MCH1) and Uses Thereof
Patent: 6,291,195 →
Application: 09/478,602 →
Imidazoline Derivatives and Uses Thereof
Patent: 6,294,566 →
Application: 09/398,861 →
Substituted indoles and uses thereof
Patent: 6,303,643 →
Application: 09/690,620 →
Dihydropyridines and new uses thereof
Patent: 6,310,076 →
Application: 09/588,973 →
Methods of Screening and Preparing a Composition Using Dna Encoding a Hypothalamic Atypical Neuropeptide Y/Peptide Yy Receptor (Y5)
Patent: 6,316,203 →
Application: 09/200,673 →
Novel Benzimidazole Derivatives
Patent: 6,316,637 →
Application: 09/232,490 →
Dna Encoding Galanin GALR3 Receptors and Uses Thereof
Patent: 6,329,197 →
Application: 08/900,230 →
Publication: US 2001/0009766
Selective Npy (Y5) Antagonists (Triazines)
Patent: 6,340,683 →
Application: 09/296,332 →
Morpholinone and morpholine derivatives and uses thereof
Patent: 6,362,182 →
Application: 09/702,015 →
A Process for Determining the Agonist or Antagonist of Galanin Receptor (GALR3)
Patent: 6,368,812 →
Application: 09/058,333 →
Aryl Sulfonamides and Sulfamide Derivatives and Uses Thereof
Patent: 6,391,877 →
Application: 09/709,036 →
Novel Benzimidazole Derivatives
Patent: 6,403,626 →
Application: 09/992,947 →
Publication: US 2002/0065307
Method of Screening Using SNORF36A Receptors
Patent: 6,413,731 →
Application: 09/518,914 →
Method of Obtaining Compositions Comprising Npy Y2 Receptor Specefic Compounds
Patent: 6,420,532 →
Application: 09/407,367 →
Novel Benzimidazole Derivatives
Patent: 6,436,982 →
Application: 09/992,956 →
Publication: US 2002/0072536
Use of Agonists or Antagonists of the 5-HT7 Receptor to Treat Disorders of the Bladder
Patent: 6,440,988 →
Application: 09/657,665 →
Dna Encoding Human Alpha 1ADRENERGIC Receptors and Uses Thereof
Patent: 6,448,011 →
Application: 09/688,415 →
Dna Encoding SNORF25 Receptor
Patent: 6,468,756 →
Application: 09/641,259 →
Dna Encoding a Human Dopamine D1 Receptor and Uses Thereof
Patent: 6,468,767 →
Application: 09/168,510 →
Novel Benzimidazole Derivatives
Patent: 6,495,583 →
Application: 10/139,824 →
Publication: US 2003/0022927
Novel Indole and Benzothiazole Derivatives
Patent: 6,498,177 →
Application: 09/965,944 →
Publication: US 2002/0049239
Morpholinone and Morpholine Derivatives and Uses Thereof
Patent: 6,531,471 →
Application: 10/017,263 →
Publication: US 2002/0068737
Selective Npy (Y5) Antagonists (Triazines)
Patent: 6,569,856 →
Application: 10/037,859 →
Publication: US 2002/0103201
Dna Encoding Galanin GALR2 Receptors and Uses Thereof
Patent: 6,586,191 →
Application: 08/899,112 →
Publication: US 2003/0082672
Use of Alpha-1C Specific Compounds to Treat Benign Prostatic Hyperplasia
Patent: 6,602,888 →
Application: 09/444,783 →
Publication: US 2002/0032219
Dihydropyridines and Uses Thereof
Patent: 6,608,086 →
Application: 09/972,801 →
Publication: US 2002/0193599
Oxazolidinones and Uses Thereof
Patent: 6,620,815 →
Application: 09/636,518 →
Methods of Modifying Feeding Behavior Using Compounds with Afinity for the Human Hypothalamic Atypical Neuropeptide Y/Peptide Yy Receptor (Y5)
Patent: 6,645,774 →
Application: 09/447,907 →
Secondary Amino Anilinic Piperidines as MCH1 Antagonists and Uses Thereof
Related Assignments (12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 16, 1999
From: JONES, KENNETH A.; LAZ, THOMAS M.; BOROWSKY, BETH
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 009762/0978 →
Assignment of Assignor's Interest Nov 12, 1999
From: GERALD, CHRISTOPHE P.G.; JONES, KENNETH A.; BONINI, JAMES A.; BOROWSKY, BETH E.
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 010409/0904 →
Assignment of Assignor's Interest Dec 10, 1999
From: GERALD, CHRISTOPHE P.G.; WEINSHANK, RICHARD L.; WALKER, MARY W.; BRANCHEK, THERESA
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 010446/0995 →
Assignment of Assignor's Interest Jun 19, 2000
From: GERALD, CHRISTOPHE P.G.; JONES, KENNETH A.; BONINI, JAMES A.; BOROWSKY, BETH E.
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 010918/0652 →
Assignment of Assignor's Interest Sep 17, 2001
From: SALON, JOHN A.; LAZ, THOMAS M.; NAGORNY, RAISA; WILSON, AMY E.
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 012182/0053 →
Assignment of Assignor's Interest Jan 28, 2002
From: SALON, JOHN A.; LAZ, THOMAS M.; NAGORNY, RAISA; WILSON, AMY E.
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 012549/0856 →
Assignment of Assignor's Interest Apr 16, 2002
From: BARD, JONATHAN A.; BOROWSKY, BETH; SMITH, KELLI E.
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 012803/0802 →
Assignment of Assignor's Interest Apr 18, 2002
From: FORRAY, CARLOS; SALON, JOHN A.; LAZ, THOMAS M.; NAGORNY, RAISA
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 012839/0458 →
Assignment of Assignor's Interest Jun 18, 2002
From: JONES, KENNETH A.; LAZ, THOMAS M.; BOROWSKY, BETH
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 013024/0790 →
Assignment of Assignor's Interest Feb 3, 2003
From: BONINI, JAMES A.; BOROWSKY, BETH E.; ADHAM, NIKA; BOYLE, NOEL
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 013710/0194 →
Assignment of Assignor's Interest Sep 22, 2003
From: SALON, JOHN A.; LAZ, THOMAS M.; NAGORNY, RAISA; WILSON, AMY E.
To: SYNAPTIC PHARMACEUTICAL CORPORATION
Reel/Frame 014512/0720 →
Assignment of Assignor's Interest Mar 8, 2010
From: BONINI, JAMES A.; BOROWSKY, BETH E.; ADHAM, NIKA; BOYLE, NOEL
To: H. LUNDBECK A/S
Reel/Frame 024045/0286 →